|
||||
|
Categories:
|
News & UpdatesNovember 11, 2008 UK Government Warns Of Adverse Reaction To Pfizer Antismoking DrugSource: CNN Money The U.K. government's regulatory agency for pharmaceuticals has warned "depression and suicide-related events" have been reported in patients using Pfizer Inc.'s (PFE) smoking-cessation aid Varenicline.
November 6, 2008 Pfizer Halts Obesity Drug on Risk of U.S. RejectionSource: Bloomberg Pfizer Inc., the world's largest drugmaker, said it will quit testing an obesity drug similar to ones junked by other companies because winning U.S. approval would be too slow, expensive and risky. November 6, 2008 Big business prepares for a less friendly Washington![]() Source: Miami Herald After years of playing offense, big business is getting ready for the less familiar role of playing defense following President-elect Barack Obama's victory and legislative gains by other Democrats.
Corporate America enjoyed... November 5, 2008 Glaxo Joins Merck, Pfizer, Wyeth Chopping Sales JobsSource: Bloomberg.com GlaxoSmithKline Plc, Europe's largest drugmaker, joined the list of pharmaceutical companies cutting sales positions in the U.S. Glaxo will end 1,000 of those jobs by year-end, said Claire Brough, a company spokeswoman, in a... November 1, 2008 Drugmakers seek lawsuit limits at top US courtSource: Reuters The U.S. Supreme Court hears arguments on Monday in a closely watched case that could limit liability claims against drugmakers if one of their medicines causes harm.
October 17, 2008 Pfizer to Settle Celebrex and Bextra SuitsSource: The Wall Street Journal Pfizer Inc. has agreed in principle to pay $894 million to settle litigation related to its painkillers Celebrex and Bextra. The bulk of the settlement, $745 million, will resolve 90% of the known personal injury suits that...
October 8, 2008
|
<-- Back to Company ListSubsectionsAccountability-Central partners with Google to bring you related links with relevant information - links below:
|
| HOME | ABOUT THE SITE | REGISTRATION INFORMATION | ADVERTISING OPPORTUNITIES | SPECIAL SECTIONS | ||
| Revised September 2007 | ||
|
||
|